| 1. Frederick W. Alt received the 2015 Szent-Gy?rgi Prize forProgress inCancer Research |
Page:101—104 |
| 2. Co-infection ofEpstein-Barr virus andhuman papillomavirus inhuman tumorigenesis |
Page:105—113 |
| 3. Phase II study ofoxaliplatin combined withS-1 andleucovorin (SOL) forChinese patients withmetastatic colorectal cancer |
Page:114—120 |
| 4. Cumulative scores based onplasma D-dimer andserum albumin levels predict survival inesophageal squamous cell carcinoma patients treated withtransthoracic esophagectomy |
Page:121—129 |
| 5. Prognostic signiifcance ofthe pre-chemotherapy lymphocyte-to-monocyte ratio inpatients withpreviously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy |
Page:130—138 |
| 6. Segmental ureteroileal conduit resection forthe treatment ofdistal upper urinary tract recurrence ofbladder cancer following cystectomy |
Page:150—155 |
| 7. Survival and clinical outcomes in patients with metastatic epidural spinal cord compression after spinal surgery：a prospective, multicenter, observational cohort study |
Page:157—159 |
| 8. Meeting report on the first Sino-Dutch symposium on oncology |
Page:160—162 |
| 9. Accelerated partial breast irradiation:advances and controversies |
Page:163—170 |
| 10. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21 |
Page:171—180 |
| 11. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma |
Page:181—189 |
| 12. Epidemiologic characteristics of oral cancer：single-center analysis of 4097 patients from the Sun Yat-sen University Cancer Center |
Page:190—195 |
| 13. Occipital lymph node metastasis from nasopharyngeal carcinoma：a special case report and literature review |
Page:196—203 |
| 14. Cell-free circulating tumor DNA in cancer |
Page:1—9 |
| 15. Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP Rs) in cancer：will they become a new battlefield for oncotherapy? |
Page:10—18 |
| 16. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China |
Page:19—24 |
| 17. Prospective, single-center cohort study analyzing the efcacy of complete laparoscopic resection on recurrent hepatocellular carcinoma |
Page:25—31 |
| 18. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection |
Page:32—45 |
| 19. Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer |
Page:46—50 |
| 20. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma |
Page:51—59 |
| 21. Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study |
Page:60—63 |
| 22. The Philadelphia chromosome in leukemogenesis |
Page:269—283 |
| 23. Association ofperioperative blood pressure withlong-term survival inrectal cancer patients |
Page:284—293 |
| 24. A new prognostic histopathologic classiifcation ofnasopharyngeal carcinoma |
Page:294—309 |
| 25. Hormonal therapy might be a better choice asmaintenance treatment thancapecitabine afterresponse toifrst-line capecitabine-based combination chemotherapy forpatients withhormone receptor-positive andHER2-negative, metastatic breast cancer |
Page:310—316 |
| 26. Forty-six cases ofnasopharyngeal carcinoma treated with50Gy radiotherapy plushematoporphyrin derivative：20years offollow-up andoutcomes fromthe Sun Yat-sen University Cancer Center |
Page:317—326 |
| 27. Prospective study found thatperipheral lymph node sampling reduced the false-negative rate ofsentinel lymph node biopsy forbreast cancer |
Page:327—332 |
| 28. Pediatric spinal glioblastoma ofthe conus medullaris：a case report oflong survival |
Page:333—336 |
| 29. The rationale forpreventing cancer cachexia：targeting excessive fatty acid oxidation |
Page:337—338 |
| 30. Long-term survival ofearly-stage non-small cell lung cancer patients who underwent robotic procedure：a propensity score-matched study |
Page:339—341 |
| 31. Genetic alteration andmutation proifling ofcirculating cell-free tumor DNA (cfDNA) fordiagnosis andtargeted therapy ofgastrointestinal stromal tumors |
Page:342—349 |
| 32. Low WT1 transcript levels atdiagnosis predicted poor outcomes ofacute myeloid leukemia patients witht(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation |
Page:350—358 |
| 33. Preoperative neutrophil-to-lymphocyte ratio plusplatelet-to-lymphocyte ratio inpredicting survival forpatients withstage I-II gastric cancer |
Page:359—365 |
| 34. Hippo/YAP signaling pathway is involved inosteosarcoma chemoresistance |
Page:366—373 |
| 35. The expression andprognostic value ofprotein tyrosine kinase 6 inearly-stage cervical squamous cell cancer |
Page:374—381 |
| 36. Radiotherapy forgynecologic cancer innonagenarian patients：a framework fornew paradigms |
Page:382—385 |
| 37. Protein stability regulators screening assay (Pro-SRSA):protein degradation meets the CRISPR-Cas9 librar y |
Page:385—387 |
| 38. Leveraging the power of pooled data for cancer outcomes research |
Page:388—390 |
| 39. The journey of personalizing gastric cancer treatment |
Page:391—392 |
| 40. Emerging molecular classiifcations and therapeutic implications for gastric cancer |
Page:393—402 |
| 41. Genomic alterations and molecular subtypes of gastric cancers in Asians |
Page:403—409 |
| 42. Evolution of gastric surger y techniques and outcomes |
Page:410—415 |
| 43. Gastric cancer:current and evolving treatment landscape |
Page:416—420 |
| 44. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma |
Page:421—429 |
| 45. The incidence and mortality of major cancers in China, 2012 |
Page:430—434 |
| 46. A comprehensive genomic characterization of esophageal squamous cell carcinoma：from prognostic analysis to in vivo assay |
Page:435—437 |
| 47. Chemotherapy in non-small cell lung cancer：opportunities for advancement |
Page:438—440 |
| 48. Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome |
Page:441—446 |
| 49. Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China：a cohort study |
Page:447—454 |
| 50. Epidemiology of lung cancer and approaches for its prediction：a systematic review and analysis |
Page:455—467 |
| 51. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen |
Page:468—475 |
| 52. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma:a 10-year retrospective study |
Page:476—484 |
| 53. What did Sun Yat-sen really die of? A re-assessment of his illness and the cause of his death |
Page:485—489 |
| 54. Chromatin remodeling factor LSH affects fumarate hydratase asa cancer driver |
Page:491—494 |
| 55. Overuse ofcolorectal cancer screening services inthe United States andits implications |
Page:495—496 |
| 56. Molecular proifles tobiology andpathways：a systems biology approach |
Page:497—499 |
| 57. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition andradioresistance ofnon-small cell lung cancer cells |
Page:500—508 |
| 58. Low expression ofcentrosomal protein 78 (CEP78) is associated withpoor prognosis ofcolorectal cancer patients |
Page:509—517 |
| 59. Colorectal cancer mortality trends inSerbia during1991-2010：an age-period-cohort analysis anda joinpoint regression analysis |
Page:518—527 |
| 60. Prognostic factors affecting postoperative survival ofpatients withsolitary small hepatocellular carcinoma |
Page:528—534 |
| 61. Outcomes ofpreoperative chemoradiotherapy followed bysurgery inpatients withunresectable locally advanced sigmoid colon cancer |
Page:535—545 |
| 62. Whole exome sequencing andsingle nucleotide polymorphism array analyses toidentify germline alterations ingenes associated withtestosterone metabolism ina patient withandrogen insensitivity syndrome andearly-onset colorectal cancer |
Page:546—559 |
| 63. Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma |
Page:641—644 |
| 64. Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma |
Page:645—646 |
| 65. Combination therapy in cancer：effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics |
Page:647—656 |
| 66. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment |
Page:658—665 |
| 67. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
Page:666—672 |
| 68. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy |
Page:673—682 |
| 69. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic signiifcance：a meta-analysis |
Page:683—698 |
| 70. Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma |
Page:699—705 |
| 71. ABO blood group is a predictor of survival in patients with laryngeal cancer |
Page:706—712 |
| 72. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma：a retrospective study |
Page:713—724 |
| 73. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy |
Page:725—734 |
| 74. Study protocol of the Asian XELIRI ProjecT (AXEPT)：a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the effcacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab |
Page:735—742 |
| 75. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma |
Page:743—753 |
